November 15, 2021 Comments Off on New patent for Gilead Sciences drug EPCLUSA Posted in: Patent Added Annual Drug Patent Expirations for EPCLUSA Epclusa is a drug marketed by Gilead Sciences Inc and is included in two NDAs. It is available from one supplier. There are fifteen…
The post New patent for Gilead Sciences drug EPCLUSA appeared first on DrugP…
November 15, 2021 Comments Off on New patent expiration for Novartis drug AMTURNIDE Posted in: Uncategorized
Annual Drug Patent Expirations for AMTURNIDE Amturnide is a drug marketed by Novartis and is included in one NDA. There are two patents protecting this drug. This drug has one…
The post New patent expiration for Novartis drug AMTURNIDE appeared first o…